Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ICLR · against 126 other Healthcare companies of similar size
Ranked #92 of 127 · scores higher than 26% of peers
Bars: peers in each 10-point band of the valuation score21 peers with a valuation score of 40–49, including ICLR · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | ICLR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 125 reported | 0.3% | 2.9% | 20% | 30% | |
| EBITDA yieldHigher is better · 128 reported | 2.9% | 5.2% | 31% | 50% | |
| Free cash flow yieldHigher is better · 83 reported | 2.8% | 3.1% | 44% | 20% | |
| Book yieldHigher is better · 124 reported | 59.7% | 21.6% | 90% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 2 | 10.4B USD | 96 | 64 | |
| 3 | 80.2B CNY (≈$11.2B) | 95 | 76 | |
| 3 | 21.5B USD | 95 | 60 | |
| 5 | 11.6B USD | 94 | 58 | |
| 88 | 27.5B NZD (≈$16.5B) | 45 | 69 | |
| 90 | 10.5B USD | 44 | 56 | |
| 90 | 871.6B INR (≈$10.5B) | 44 | 66 | |
| 92 | 16.9B USD | 43 | 37 | |
| 92 | 15.7B USD | 43 | 33 | |
| 92 | 1.77T INR (≈$21.2B) | 43 | 57 | |
| 95 | 64.1B CNY (≈$9.0B) | 41 | 48 | |
| 95 | 13.2B USD | 41 | 30 | |
| 95 | 10.8B USD | 41 | 41 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score